trending Market Intelligence /marketintelligence/en/news-insights/trending/vqbwxauzidldh0srbwdmoa2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Compugen appoints chief medical officer

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Compugen appoints chief medical officer

Compugen Ltd. appointed Henry Adewoye to the newly created role of chief medical officer, effective March 26.

Adewoye most recently served as clinical director in oncology clinical research at Gilead Sciences Inc.

Tel Aviv-based Compugen is a therapeutic discovery and development company working to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy.